212 related articles for article (PubMed ID: 24292708)
1. Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity.
Berezhnoy A; Castro I; Levay A; Malek TR; Gilboa E
J Clin Invest; 2014 Jan; 124(1):188-97. PubMed ID: 24292708
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.
Aghamohammadzadeh R; Zhang YY; Stephens TE; Arons E; Zaman P; Polach KJ; Matar M; Yung LM; Yu PB; Bowman FP; Opotowsky AR; Waxman AB; Loscalzo J; Leopold JA; Maron BA
FASEB J; 2016 Jul; 30(7):2511-27. PubMed ID: 27006450
[TBL] [Abstract][Full Text] [Related]
3. Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.
Yi H; Guo C; Yu X; Gao P; Qian J; Zuo D; Manjili MH; Fisher PB; Subjeck JR; Wang XY
Cancer Res; 2011 Nov; 71(21):6611-20. PubMed ID: 21914786
[TBL] [Abstract][Full Text] [Related]
4. Development of a potent melanoma vaccine capable of stimulating CD8(+) T-cells independently of dendritic cells in a mouse model.
Powell KL; Stephens AS; Ralph SJ
Cancer Immunol Immunother; 2015 Jul; 64(7):861-72. PubMed ID: 25893808
[TBL] [Abstract][Full Text] [Related]
5. Amino acids and RagD potentiate mTORC1 activation in CD8
Zhang Y; Hu H; Liu W; Yan SM; Li Y; Tan L; Chen Y; Liu J; Peng Z; Yuan Y; Huang W; Yu F; He X; Li B; Zhang H
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883257
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice.
Amiel E; Everts B; Freitas TC; King IL; Curtis JD; Pearce EL; Pearce EJ
J Immunol; 2012 Sep; 189(5):2151-8. PubMed ID: 22826320
[TBL] [Abstract][Full Text] [Related]
7. Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice.
Hurez V; Dao V; Liu A; Pandeswara S; Gelfond J; Sun L; Bergman M; Orihuela CJ; Galvan V; Padrón Á; Drerup J; Liu Y; Hasty P; Sharp ZD; Curiel TJ
Aging Cell; 2015 Dec; 14(6):945-56. PubMed ID: 26315673
[TBL] [Abstract][Full Text] [Related]
8. Cutting Edge: mTORC2 Regulates CD8+ Effector and Memory T Cell Differentiation through Serum and Glucocorticoid Kinase 1.
Patel CH; Heikamp EB; Xu W; Sun IH; Oh MH; Sun IM; Wen J; Tam AJ; Blosser RL; Powell JD
J Immunol; 2022 Dec; 209(12):2287-2291. PubMed ID: 36469844
[TBL] [Abstract][Full Text] [Related]
9. Akt signaling is critical for memory CD8
Rogel A; Willoughby JE; Buchan SL; Leonard HJ; Thirdborough SM; Al-Shamkhani A
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1178-E1187. PubMed ID: 28137869
[TBL] [Abstract][Full Text] [Related]
10. Pathogen-Boosted Adoptive Cell Transfer Therapy Induces Endogenous Antitumor Immunity through Antigen Spreading.
Xin G; Khatun A; Topchyan P; Zander R; Volberding PJ; Chen Y; Shen J; Fu C; Jiang A; See WA; Cui W
Cancer Immunol Res; 2020 Jan; 8(1):7-18. PubMed ID: 31719059
[TBL] [Abstract][Full Text] [Related]
11. The role of mTOR in memory CD8 T-cell differentiation.
Araki K; Youngblood B; Ahmed R
Immunol Rev; 2010 May; 235(1):234-43. PubMed ID: 20536567
[TBL] [Abstract][Full Text] [Related]
12. TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy.
Patel CH; Dong Y; Koleini N; Wang X; Dunkerly-Eyring BL; Wen J; Ranek MJ; Bartle LM; Henderson DB; Sagert J; Kass DA; Powell JD
JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37788104
[TBL] [Abstract][Full Text] [Related]
13. NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.
Gu M; Zhou X; Sohn JH; Zhu L; Jie Z; Yang JY; Zheng X; Xie X; Yang J; Shi Y; Brightbill HD; Kim JB; Wang J; Cheng X; Sun SC
Nat Immunol; 2021 Feb; 22(2):193-204. PubMed ID: 33398181
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity.
Garrido G; Schrand B; Rabasa A; Levay A; D'Eramo F; Berezhnoy A; Modi S; Gefen T; Marijt K; Doorduijn E; Dudeja V; van Hall T; Gilboa E
Nat Commun; 2019 Aug; 10(1):3773. PubMed ID: 31434881
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T cells regulate bone tumor burden independent of osteoclast resorption.
Zhang K; Kim S; Cremasco V; Hirbe AC; Collins L; Piwnica-Worms D; Novack DV; Weilbaecher K; Faccio R
Cancer Res; 2011 Jul; 71(14):4799-808. PubMed ID: 21602433
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD8
Chen Y; Xu Z; Sun H; Ouyang X; Han Y; Yu H; Wu N; Xie Y; Su B
Cell Mol Immunol; 2023 Sep; 20(9):1023-1039. PubMed ID: 37582972
[TBL] [Abstract][Full Text] [Related]
17. p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8⁺ T cells.
Henson SM; Lanna A; Riddell NE; Franzese O; Macaulay R; Griffiths SJ; Puleston DJ; Watson AS; Simon AK; Tooze SA; Akbar AN
J Clin Invest; 2014 Sep; 124(9):4004-16. PubMed ID: 25083993
[TBL] [Abstract][Full Text] [Related]
18. Yap suppresses T-cell function and infiltration in the tumor microenvironment.
Stampouloglou E; Cheng N; Federico A; Slaby E; Monti S; Szeto GL; Varelas X
PLoS Biol; 2020 Jan; 18(1):e3000591. PubMed ID: 31929526
[TBL] [Abstract][Full Text] [Related]
19. Impaired T cell proliferation by
Chee J; Wilson C; Buzzai A; Wylie B; Forbes CA; Booth M; Principe N; Foley B; Cruickshank MN; Waithman J
Epigenetics; 2020; 15(1-2):134-144. PubMed ID: 31423932
[TBL] [Abstract][Full Text] [Related]
20. P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy.
Wanhainen KM; Peng C; Zhou MH; Macedo BG; O'Flanagan S; Yang T; Kelekar A; Burbach BJ; Borges da Silva H; Jameson SC
Cancer Immunol Res; 2022 Jul; 10(7):871-884. PubMed ID: 35588154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
